Questions Remain about Targeted Temperature Management in Cardiac Arrest.
NEJM Evid
; 1(11): EVIDe2200247, 2022 Nov.
Article
en En
| MEDLINE
| ID: mdl-38319860
ABSTRACT
For decades, targeted temperature management (TTM) has been a promising intervention for mitigating brain damage after cardiac arrest. Early landmark studies of TTM for out-of-hospital cardiac arrests (OHCAs) with shockable rhythms showed benefits in mortality and neurologic outcome.1,2 On the basis of these results, TTM was established as standard practice and was given a class I recommendation in the 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care for use in OHCA with initial shockable rhythms, as well as a class IIb recommendation in patients with initial nonshockable rhythms and for in-hospital cardiac arrests (IHCAs).3.
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Reanimación Cardiopulmonar
/
Servicios Médicos de Urgencia
/
Paro Cardíaco Extrahospitalario
/
Hipotermia Inducida
Tipo de estudio:
Guideline
Límite:
Humans
País/Región como asunto:
America do norte
Idioma:
En
Revista:
NEJM Evid
Año:
2022
Tipo del documento:
Article
Pais de publicación:
Estados Unidos